Literature DB >> 7507535

Early structural changes in hypertension: pathophysiology and clinical consequences.

B Folkow1.   

Abstract

The structural upward resetting of heart, vessels, and barostat functions represents what may be the most important long-term cardiovascular alteration in hypertension; the altered geometric design of the systemic precapillary resistance vessels is of profound hemodynamic relevance. This is especially true in primary (essential) hypertension, for which three major etiological elements can be distinguished: polygenetic predisposition, environmental factors, and the structural factor. The physical and biological principles behind the early "structural upward resetting" of heart and vessels in hypertension are outlined and experimentally illustrated. Further, the long-term hemodynamic effects of this per se "normal" structural adaptation are discussed, particularly concerning systemic precapillary resistance, but also concerning the heart, barostat mechanisms of reflex and renal nature, and the venous capacitance vessels. With this background in mind, the primary long-term goal of therapy must be to reverse these structural changes toward normal cardiovascular design and dimensions, whereas in the future preventive measures may be actualized. Thus, treatment should serve not only to reduce the increased load on heart and vessels but also, wherever possible, to reduce the influence of trophic, growth-promoting factors of local and remote nature, as exemplified by model studies in rats.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7507535

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  8 in total

Review 1.  The prognostic significance of heart rate for cardiovascular disease and hypertension.

Authors:  Trygve B Tjugen; Arnljot Flaa; Sverre E Kjeldsen
Journal:  Curr Hypertens Rep       Date:  2010-06       Impact factor: 5.369

2.  To be or not to be ... hypertensive: that is the question.

Authors:  David S Gardner
Journal:  J Physiol       Date:  2008-10-01       Impact factor: 5.182

3.  Genome-wide case/control studies in hypertension: only the 'tip of the iceberg'.

Authors:  Kuixing Zhang; Alan B Weder; Eleazar Eskin; Daniel T O'Connor
Journal:  J Hypertens       Date:  2010-06       Impact factor: 4.844

Review 4.  Deciphering actin cytoskeletal function in the contractile vascular smooth muscle cell.

Authors:  Rina Yamin; Kathleen G Morgan
Journal:  J Physiol       Date:  2012-06-11       Impact factor: 5.182

5.  Croton membranaceus Improves Some Biomarkers of Cardiovascular Disease and Diabetes in Genetic Animal Models.

Authors:  George Awuku Asare; Samuel Adjei; Daniel Afriyie; Akua Bempomaa Appiah-Danquah; Jonas Asia; Bernice Asiedu; Sheila Santa; Derek Doku
Journal:  J Clin Diagn Res       Date:  2015-12-01

Review 6.  Mechanotransduction in vascular physiology and atherogenesis.

Authors:  Cornelia Hahn; Martin A Schwartz
Journal:  Nat Rev Mol Cell Biol       Date:  2009-01       Impact factor: 94.444

7.  Mito-tempol and dexrazoxane exhibit cardioprotective and chemotherapeutic effects through specific protein oxidation and autophagy in a syngeneic breast tumor preclinical model.

Authors:  Jennifer S Dickey; Yanira Gonzalez; Baikuntha Aryal; Steven Mog; Asako J Nakamura; Christophe E Redon; Ulrich Baxa; Elliot Rosen; Gang Cheng; Jacek Zielonka; Palak Parekh; Karen P Mason; Joy Joseph; Balaraman Kalyanaraman; William Bonner; Eugene Herman; Emily Shacter; V Ashutosh Rao
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

8.  Murine Models of Heart Failure with Preserved Ejection Fraction: a "Fishing Expedition".

Authors:  Maria Valero-Muñoz; Warren Backman; Flora Sam
Journal:  JACC Basic Transl Sci       Date:  2017-12-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.